ANI PHARMACEUTICALS INC. - COMMON STOCK
58.59
04-فبراير-25 16:45:00
15 متأخرة بدقائق
الأسهم
+0.68
+1.17%
نطاق اليوم
57.50 - 59.19
ISIN
N/A
المصدر
NASDAQ
-
ANI Pharmaceuticals Announces the FDA Approval and Launch of Indomethacin Oral Suspension, USP
16 يناير 2024 06:50:00 بحسب Nasdaq GlobeNewswire
-
ANI Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference
22 نوفمبر 2023 09:26:49 بحسب Nasdaq GlobeNewswire
-
08 نوفمبر 2023 06:50:00 بحسب Nasdaq GlobeNewswire
-
ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences
30 أكتوبر 2023 06:50:00 بحسب Nasdaq GlobeNewswire
-
25 أكتوبر 2023 06:50:00 بحسب Nasdaq GlobeNewswire
-
ANI Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023
18 سبتمبر 2023 16:05:00 بحسب Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Tablets USP
12 سبتمبر 2023 06:50:00 بحسب Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.1%
28 أغسطس 2023 06:50:00 بحسب Nasdaq GlobeNewswire
-
ANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
24 أغسطس 2023 06:50:00 بحسب Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Appoints Healthcare Executive Matthew J. Leonard to its Board of Directors
23 أغسطس 2023 06:50:00 بحسب Nasdaq GlobeNewswire
-
09 أغسطس 2023 06:50:31 بحسب Nasdaq GlobeNewswire
-
31 يوليو 2023 07:17:19 بحسب Nasdaq GlobeNewswire